Ž. Reiner

发表

Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model.

J. De Sutter, E. Mirrakhimov, G. De Backer, 2020, European journal of preventive cardiology.

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study

J. De Sutter, P. Heuschmann, P. Amouyel, 2018, European Journal of Epidemiology.

Comorbidity, multimorbidity and personalized psychosomatic medicine: epigenetics rolling on the horizon.

Miro Jakovljević, Ž. Reiner, D. Miličić, 2010, Psychiatria Danubina.

Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection

J. Sharifi‐Rad, C. F. Rodrigues, Rajanish Giri, 2021, Frontiers in Pharmacology.

Passive smoking and smoking cessation among patients with coronary heart disease across Europe: results from the EUROASPIRE III survey.

J. Wellmann, D. De Bacquer, K. Kotseva, 2014, European heart journal.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

P. Kolh, M. Taskinen, G. De Backer, 2011, European heart journal.

Lipoprotein(a) as a cardiovascular risk factor: current status

J. Borén, M. Taskinen, G. Watts, 2010, European heart journal.

2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2007, Blood pressure.

Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy

Ž. Reiner, 2018, Korean circulation journal.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit

Shah Ebrahim, Harry Hemingway, Silvia G Priori, 2007, European heart journal.

European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

Shah Ebrahim, Ian Graham, Jose Luis Zamorano, 2012, International Journal of Behavioral Medicine.

Third universal definition of myocardial infarction.

Jeroen J. Bax, P. Kirchhof, D. Atar, 2012, Global heart.

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

Stefan Störk, Lale Tokgözoğlu, Philippe Amouyel, 2016, European journal of preventive cardiology.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Helmut Baumgartner, Stein Ørn, Juerg Schwitter, 2012, European journal of heart failure.

2010 Focused Update of ESC Guidelines on device therapy in heart failure

Jeroen J. Bax, J. Daubert, P. Ponikowski, 2010, European journal of heart failure.

The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology.

J. De Sutter, G. De Backer, D. De Bacquer, 2016, International journal of cardiology.

Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy

G. Mancia, L. Ruilope, G. De Backer, 2012, European journal of preventive cardiology.

Hypertriglyceridaemia and risk of coronary artery disease

Ž. Reiner, 2017, Nature Reviews Cardiology.

Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?

Ž. Reiner, 2015, Cardiology.

Continental-Mediterranean and rural-urban differences in cardiovascular risk factors in Croatian population

J. Vučak, Ž. Reiner, J. Kern, 2011, Croatian medical journal.

Impact of Treating Dyslipidemia on Cardiovascular Events

Ž. Reiner, D. Muačević-Kataneć, 2011 .

Combined therapy in the treatment of dyslipidemia

Ž. Reiner, 2010, Fundamental & Clinical Pharmacology.

[Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].

Ž. Reiner, M. Galić, M. Hanževački, 2005, Liječnički vjesnik.

Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

Shah Ebrahim, Silvia G. Priori, Ian Graham, 2007 .

European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

Shah Ebrahim, Silvia G Priori, Ian Graham, 2007, Atherosclerosis.

Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

Shah Ebrahim, Silvia G. Priori, Ian Graham, 2007 .

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

J. Car, H. Schunkert, S. Yamashita, 2018, Atherosclerosis.

Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies.

D. Solter, Ž. Reiner, P. Alaupovic, 1986, Biochimica et Biophysica Acta.

Prevencija kardiovaskularnih bolesti u starijih osoba

Ž. Reiner, E. Tedeschi-Reiner, 2005 .

Genistein as a regulator of signaling pathways and microRNAs in different types of cancers

J. Sharifi‐Rad, S. Raza, Ž. Reiner, 2021, Cancer Cell International.

Quercetin as a Novel Therapeutic Approach for Lymphoma

J. Sharifi‐Rad, W. Cho, Ž. Reiner, 2021, Oxidative Medicine and Cellular Longevity.

Impact of Early Evidence of Atherosclerotic Changes on Early Treatment in Children With Familial Hypercholesterolemia

Ž. Reiner, 2014, Circulation research.

Zeljko Reiner With Familial Hypercholesterolemia Impact of Early Evidence of Atherosclerotic Changes on Early Treatment in Children

Ž. Reiner, 2022 .

Fetal toxicity associated with statins: A systematic review and meta-analysis.

A. Sahebkar, M. Banach, Ž. Reiner, 2021, Atherosclerosis.

The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis

Ž. Reiner, F. Montecucco, F. Carbone, 2019, Biomolecules.

Statins in heart failure - a failure?

Ž. Reiner, 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair

Ž. Reiner, Z. Asemi, Parinaz Zivarpour, 2020, Heart Failure Reviews.

The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.

D. Panagiotakos, W. März, M. Banach, 2019, Atherosclerosis. Supplements.

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel#

D. Panagiotakos, B. Paulweber, A. Sahebkar, 2017, Archives of medical science : AMS.

New ESC/EAS Guidelines for the management of dyslipidaemias − any controversies behind the consensus?

Ž. Reiner, 2011, European Journal of Cardiovascular Prevention & Rehabilitation.

Peripheral arterial disease and intermittent claudication in coronary heart disease patients.

J. De Sutter, E. Mirrakhimov, D. De Bacquer, 2020, International journal of cardiology.

Population-level changes to promote cardiovascular health

O. Franco, J. De Sutter, P. Marques‐Vidal, 2012, European journal of preventive cardiology.

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Helmut Baumgartner, Ottavio Alfieri, Ulrich Schotten, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel

M. Banach, G. Watts, K. Widhalm, 2021, Journal of clinical medicine.

Shah Ebrahim, Silvia G Priori, Ian Graham, 2007, European heart journal.

Statins for primary prevention: problems with cardiovascular-risk estimation?

Ž. Reiner, 2013, Nature Reviews Cardiology.

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.

J. De Sutter, P. Amouyel, G. De Backer, 2018, International journal of cardiology.

The Role of Nutrition in the Prevention and Treatment of Cardiovascular Diseases

Ž. Reiner, 2022 .

Changing People’s Habits-Main Factor in the Treatment of Hyperlipidemias

Ž. Reiner, 2000 .

European guidelines on cardiovascular disease prevention in clinical practice

Shah Ebrahim, Silvia G. Priori, Ian Graham, 2004 .

Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ.

B. Jelaković, Ž. Reiner, J. Sertić, 2014, Genetic Testing and Molecular Biomarkers.

Differences in risk factors for coronary heart disease in patients from continental and Mediterranean regions of Croatia

Ž. Reiner, D. Miličić, M. Bergovec, 2008, Wiener klinische Wochenschrift.

The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP).

A. Khera, D. Panagiotakos, J. Jozwiak, 2020, Clinical nutrition.

Statin therapy in athletes and patients performing regular intense exercise - Position Paper from the International Lipid Expert Panel (ILEP).

E. Mirrakhimov, A. Sahebkar, M. Banach, 2020, Pharmacological research.

The Effect of Bariatric Surgery on Circulating Levels of Oxidized Low-Density Lipoproteins Is Apparently Independent of Changes in Body Mass Index: A Systematic Review and Meta-Analysis

M. Kroh, A. Sahebkar, R. Santos, 2021, Oxidative medicine and cellular longevity.

Guidelines on CVD prevention: confusing or complementary?

G. De Backer, O. Wiklund, Ž. Reiner, 2013, European journal of preventive cardiology.

The effects of catechin on endothelial function: A systematic review and meta-analysis of randomized controlled trials

A. Milajerdi, Ž. Reiner, F. Kolahdooz, 2020, Critical reviews in food science and nutrition.

Novel Experimental Agents for the Treatment of Hypercholesterolemia

I. Pećin, Ž. Reiner, 2021, Journal of experimental pharmacology.

Metabolic Syndrome, Morbidity and Mortlity - in the Era of COVID-19 Pandemic.

I. Pećin, Ž. Reiner, 2021, Psychiatria Danubina.

Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases

Ž. Reiner, M. Ruscica, A. Sahebkar, 2022, Journal of clinical medicine.

[2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].

A. Hoes, M. Taskinen, G. De Backer, 2016, Kardiologia polska.

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

J. Car, H. Schunkert, S. Yamashita, 2016, Atherosclerosis. Supplements.

The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

R. Santos, Ž. Reiner, Suowen Xu, 2021, Mediators of inflammation.

Effects of flaxseed oil supplementation on biomarkers of inflammation and oxidative stress in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials.

M. Mansournia, A. Milajerdi, Ž. Reiner, 2020, Clinical Nutrition ESPEN.

Polypill is not a ‘vaccine-like’ solution for primary cardiovascular disease prevention in all parts of the world

Ž. Reiner, 2013, Journal of Epidemiology & Community Health.

The effects of grape seed extract on glycemic control, serum lipoproteins, inflammation, and body weight: A systematic review and meta‐analysis of randomized controlled trials

Ž. Reiner, F. Kolahdooz, Z. Asemi, 2019, Phytotherapy research : PTR.

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

Deepak L. Bhatt, R. Diaz, H. White, 2019, Circulation.

The Effects of N-acetylcysteine on Inflammatory Markers and Homocysteine: A Systematic Review and Meta-analysis of Randomized Controlled Trials

A. Milajerdi, Ž. Reiner, F. Kolahdooz, 2020 .

Thigh abscess as an extension of psoas abscess: the first manifestation of perforated appendiceal adenocarcinoma: case report

G. Augustin, I. Pećin, Ž. Reiner, 2015, Wiener klinische Wochenschrift.

Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

M. Banach, Ž. Reiner, A. Sahebkar, 2017, Cardiovascular Drugs and Therapy.

OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP).

M. Banach, C. Vlachopoulos, D. Dudek, 2021, Pharmacological research.

Statistical vs clinical significance: A matter of debate for orlistat treatment.

P. Kovanen, Ž. Reiner, A. Sahebkar, 2017, Pharmacological research.

Can Lp(a) Lowering Against Background Statin Therapy Really Reduce Cardiovascular Risk?

Ž. Reiner, 2019, Current Atherosclerosis Reports.

The effects of L-carnitine supplementation on glycemic control: a systematic review and meta-analysis of randomized controlled trials

A. Milajerdi, Ž. Reiner, F. Kolahdooz, 2019, EXCLI Journal : Experimental and Clinical Sciences.

How to improve cardiovascular diseases prevention in Europe?

Ž. Reiner, 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Medicinal plants and bioactive natural compounds as inhibitors of HMG‐CoA reductase: A literature review

Atena Mahdavi, Ž. Reiner, Suowen Xu, 2020, BioFactors.

The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu

M. Banach, Ž. Reiner, A. Sahebkar, 2019, Journal of Clinical Medicine.

The importance of smoking cessation in patients with coronary heart disease.

Ž. Reiner, 2018, International Journal of Cardiology.

Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis

Ž. Reiner, G. Derosa, P. Maffioli, 2016, Drugs.

Comment to the position paper on global recommendations for the management of dyslipidemia developed by the International Atherosclerosis Society (IAS).

M. Taskinen, G. De Backer, O. Wiklund, 2014, Atherosclerosis.

Guidelines on CVD prevention: confusing or complementary?

G. De Backer, O. Wiklund, Ž. Reiner, 2013, Atherosclerosis.

Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.

B. Jelaković, I. Pećin, Ž. Reiner, 2013, Collegium Antropologicum.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Improvement of endothelial function by pitavastatin: a meta-analysis

A. Sahebkar, D. Mikhailidis, Ž. Reiner, 2018, Expert opinion on pharmacotherapy.

Treatment of children with homozygous familial hypercholesterolaemia

Ž. Reiner, 2018, European Journal of Preventive Cardiology.

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

G. Francis, R. Hegele, M. Reijman, 2022, The Lancet.

Treatment of children with heterozygous familial hypercholesterolemia.

A. Sahebkar, Ž. Reiner, 2019, International journal of cardiology.

[Three-year-old boy--a homozygote for familiar hypercholesterolemia].

Anita Špehar Uroić, P. Kes, Ž. Reiner, 2007, Lijecnicki vjesnik.

Methotrexate for Cardiovascular Risk Reduction: The Right Choice?

M. Banach, C. Sirtori, Ž. Reiner, 2020, Angiology.

Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes: A Global Case-Control Study in 13 Countries Running title: Sacks et al.; Plasma lipids in diabetic microvascular disease

F. Sacks, E. Bonora, C. Wanner, 2013 .

The effects of omega-3 fatty acids from flaxseed oil on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

M. Mansournia, Ž. Reiner, M. Taghizadeh, 2020, British Journal of Nutrition.

Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity

B. Jelaković, Ž. Reiner, J. Sertić, 2009, BMC Research Notes.

Triglyceride-poor very low density lipoprotein in human serum.

Ž. Reiner, E. Koren, 1979, Clinica chimica acta; international journal of clinical chemistry.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Perry M. Elliott, Jose Luis Zamorano, Luigi Tavazzi, 2010, European journal of heart failure.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Juerg Schwitter, Michael Böhm, Volkmar Falk, 2010, European journal of heart failure.

Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units

M. Banach, Ž. Reiner, Y. Panahi, 2019, Journal of Clinical Medicine.

PCSK9 and infection: A potentially useful or dangerous association?

A. Sahebkar, M. Banach, Ž. Reiner, 2018, Journal of cellular physiology.

PCSK9 inhibitors – past, present and future

Ž. Reiner, 2015, Expert opinion on drug metabolism & toxicology.

Impact of Statin Therapy on Plasma Vitamin D Levels: A Systematic Review and Meta-Analysis.

A. Sahebkar, Ž. Reiner, V. Nobili, 2017, Current pharmaceutical design.

GUIDELINES FOR THE PREVENTION, DETECTION AND THERAPY OF VITAMIN D DEFICIENCY IN ADULTS.

M. B. Pašić, Ž. Reiner, B. Anić, 2016, Lijecnicki vjesnik.

The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis

A. Sahebkar, G. Watts, Ž. Reiner, 2022, Oxidative medicine and cellular longevity.

Adverse effects of statins - myths and reality.

Ž. Reiner, I. Šimić, 2015, Current pharmaceutical design.

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.

E. Mirrakhimov, M. Banach, G. Latkovskis, 2018, Vnitrni lekarstvi.

Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus.

I. Pećin, Ž. Reiner, E. Tedeschi-Reiner, 2013, Collegium Antropologicum.

The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials

M. Mansournia, A. Milajerdi, Ž. Reiner, 2020, Journal of Diabetes and Metabolic Disorders.

Plasminogen polymorphism in swine.

S. Ye, Ž. Reiner, J. Hasler-Rapacz, 1989, Comparative biochemistry and physiology. B, Comparative biochemistry.

The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis

M. Kroh, A. Sahebkar, C. Sirtori, 2022, BioMed research international.

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology.

E. Mirrakhimov, M. Banach, G. Latkovskis, 2018, Vnitrni lekarstvi.

Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials.

A. Sahebkar, M. Banach, C. Sirtori, 2018, Journal of Clinical Lipidology.

[Should we begin with statin therapy in acute coronary syndrome?].

Ž. Reiner, 2004, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

The Effects of Statin Treatment on Serum Ferritin Levels: A Systematic Review and Meta-Analysis

A. Sahebkar, Ž. Reiner, M. Rizzo, 2022, Journal of Clinical Medicine.

Effects of Statins on Renin–Angiotensin System

Ž. Reiner, M. Ruscica, N. Kiaie, 2021, Journal of Cardiovascular Development and Disease.

Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.

Ž. Reiner, K. Kranjčević, B. Marković, 2005, Croatian medical journal.

New Therapeutic Approaches in Treatment of Dyslipidaemia—A Narrative Review

Ž. Reiner, A. Slišković, I. Merćep, 2022, Pharmaceuticals.

A Modified Physical Disability Screening Model after Treatment in the Intensive Care Unit: A Nationwide Derivation-Validation Study

A. Sahebkar, Mohammad Asghari-Jafarabadi, Ž. Reiner, 2022, Journal of Clinical Medicine.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Juerg Schwitter, Michael Böhm, Angelo Auricchio, 2010, European journal of heart failure.

Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A Position Paper of the International Lipid Expert Panel.

A. Sahebkar, M. Banach, G. Latkovskis, 2022, Pharmacological research.

Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia

M. Banach, G. Latkovskis, D. Pella, 2021, Archives of medical science : AMS.

The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial.

Ž. Reiner, Z. Asemi, E. Aghadavod, 2020, Iranian Journal of Kidney Diseases.

Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial.

Deepak L. Bhatt, A. Parkhomenko, R. Diaz, 2020, European journal of preventive cardiology.

Combination therapy with prescription omega-3-acid ethyl esters and statin improves non-HDL-C more effectively than statin alone

Ž. Reiner, 2010 .

The association between lipid-lowering drugs and circulating concentration of PCSK9

Ž. Reiner, 2019, European Journal of Preventive Cardiology.

Biosynthesized silver nanoparticles and miR34a mimics mediated activation of death receptor in MCF-7 human breast cancer cell lines

J. Sharifi‐Rad, Ž. Reiner, Monica Butnariu, 2022, Cancer Nanotechnology.

The effects of L-carnitine supplementation on serum lipids: A systematic review and meta-analysis of randomized controlled trials.

A. Milajerdi, Ž. Reiner, F. Kolahdooz, 2019, Current pharmaceutical design.

Are endogenous sex hormones important for atherosclerotic cardiovascular disease risk in men?

Ž. Reiner, 2022, Atherosclerosis.

Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?

Ž. Reiner, 2022, Journal of clinical medicine.

[European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)].

Shah Ebrahim, Ian Graham, Jose Luis Zamorano, 2013, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

Ian Graham, Gabriele Riccardi, Eduardo Alegria, 2011, Atherosclerosis.

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

J. Borén, M. Taskinen, G. Watts, 2011, European heart journal.

Effects of resistant starch on glycemic control, serum lipoproteins and systemic inflammation in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled clinical trials

A. Milajerdi, Ž. Reiner, F. Kolahdooz, 2020, Critical reviews in food science and nutrition.

Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes: A Global Case-Control Study in 13 Countries

F. Sacks, E. Bonora, C. Wanner, 2013 .

Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey.

Ž. Reiner, E. Tedeschi-Reiner, Z. Sonicki, 2010, Atherosclerosis.

Why might visit-to visit variability of lipoproteins have an effect on cardiovascular events?

Ž. Reiner, 2020, Atherosclerosis.

Th-W47:2 Atherosclerosis — A paradox of Eastern European countries

Ž. Reiner, E. Tedeschi-Reiner, 2006 .

Alirocumab: targeting PCSK9 to treat hypercholesterolemia.

I. Pećin, Ž. Reiner, Ivan Pećin, 2015, Drugs of Today.

Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis

A. Sahebkar, W. Almahmeed, Ž. Reiner, 2022, Journal of Clinical Medicine.

Symptomatic hypomagnesemia associated with gentamicin therapy.

P. Kes, Ž. Reiner, 1990, Magnesium and trace elements.

Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR (Part II)

H. Heidbuchel, T. Takken, A. Cohen-Solal, 2012, European journal of preventive cardiology.

Effects of statins on preeclampsia: A systematic review.

Ž. Reiner, A. Sahebkar, A. vahedian-azimi, 2020, Pregnancy hypertension.

2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy

A. Sahebkar, M. Banach, D. Pella, 2022, Archives of medical science : AMS.

An increase in micropulmonary red cell mass in hyperlipidaemic patients.

Ž. Reiner, J. Tocilj, I. Pintarić, 1995, Clinical Physiology.

Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia.

Ž. Reiner, D. Eterović, J. Tocilj, 2001, Atherosclerosis.

Effect of statins on abdominal aortic aneurysm.

A. Sahebkar, A. Hosseini, Ž. Reiner, 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[POMPE DISEASE - GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF ADULT PATIENTS].

I. Pećin, Ž. Reiner, K. Potočki, 2015, Liječnički vjesnik.

Is there any association between plasma lipid profile and severity of COVID-19?

A. Sahebkar, Ž. Reiner, A. vahedian-azimi, 2022, Clinical Nutrition ESPEN.

Determinants of plasma viscosity in primary hyperlipoproteinemias

Ž. Reiner, D. Eterović, J. Tocilj, 1995 .

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review

Ž. Reiner, I. Merćep, Dominik Strikić, 2022, Cardiovascular Therapeutics.

Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu

A. Sahebkar, M. Maleki, Ž. Reiner, 2022, Journal of clinical medicine.

Pathophysiology and Classification of Cardiovascular Diseases Caused by Atherosclerosis

Ž. Reiner, 2003, EJIFCC.

Protective effect of Bridelia tomentosa due to its phenolic acids and flavonoids against oxidative stress-mediated hepatic toxicity induced by carbofuran

J. Sharifi‐Rad, M. Martorell, Ž. Reiner, 2021 .

Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome - A case report.

B. Jelaković, I. Pećin, F. Borovečki, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

A. Sahebkar, M. Banach, Ž. Reiner, 2022, Cardiovascular Diabetology.

Endogenous steroid sex hormones and atherosclerosis of retinal arteries in men.

Ž. Reiner, E. Tedeschi-Reiner, R. Ivekovic, 2009, Medical science monitor : international medical journal of experimental and clinical research.

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.

J. Zamorano, P. Filardi, R. Ferrari, 2015, Atherosclerosis. Supplements.

32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT

J. Borén, M. Taskinen, G. Watts, 2011 .

P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel

J. Jozwiak, M. Mazidi, A. Sahebkar, 2019, European Heart Journal.

PCSK9 inhibitors in clinical practice: Expectations and reality.

Ž. Reiner, 2018, Atherosclerosis.

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis

A. Sahebkar, Ž. Reiner, P. Kesharwani, 2022, Journal of clinical medicine.

Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke.

I. Pećin, Ž. Reiner, J. Sertić, 2020, Gene.

Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases

Ž. Reiner, Seyed Saeed Tamehri Zadeh, A. Sahebkar, 2022, InflammoPharmacology.

Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.

Ž. Reiner, B. Vizner, M. Sekso, 2009, Experimental and clinical endocrinology.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

A. Hoes, M. Taskinen, G. De Backer, 2016, European heart journal.

Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques

G. Mancia, L. Ruilope, G. De Backer, 2012, Fundamental & clinical pharmacology.

[ESC/EAS Guidelines for the management of dyslipidaemias].

M. Taskinen, G. De Backer, S. Agewall, 2011, Revista espanola de cardiologia.

Prevalence of statin intolerance: a meta-analysis

M. Mazidi, A. Sahebkar, M. Banach, 2022, European heart journal.

Impact of Bariatric Surgery on Pulse Wave Velocity as a Measure of Arterial Stiffness: a Systematic Review and Meta-analysis

M. Kroh, A. Sahebkar, Ž. Reiner, 2021, Obesity Surgery.

Effects of whey protein on glycemic control and serum lipoproteins in patients with metabolic syndrome and related conditions: a systematic review and meta-analysis of randomized controlled clinical trials

M. Mansournia, A. Milajerdi, Ž. Reiner, 2020, Lipids in health and disease.

Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials.

A. Sahebkar, M. Banach, C. Sirtori, 2018, Journal of clinical lipidology.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention

A. Hoes, M. Taskinen, G. De Backer, 2016, Atherosclerosis.

Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19.

B. Salehi, J. Sharifi‐Rad, D. Calina, 2021, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action

C. Tonelli, K. Petroni, B. Salehi, 2020, Frontiers in Pharmacology.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential

P. Libby, P. Ridker, J. Després, 2019, Cardiovascular Diabetology.

Oxidative stress mediated cytogenotoxicological effects of phytol in wistar albino rats

J. Sharifi‐Rad, M. Martorell, Ž. Reiner, 2022, Advances in Traditional Medicine.

Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic

M. Banach, D. Pella, S. Nabavi, 2020, Pharmacological Research.

[Gaucher disease--guidelines for diagnosis and management of adult patients].

I. Pećin, Ž. Reiner, D. Muačević-Kataneć, 2014, Lijecnicki vjesnik.

A review of gene‐ and cell‐based therapies for familial hypercholesterolemia

M. Banach, Ž. Reiner, A. Sahebkar, 2019, Pharmacological research.

Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP)

M. Banach, N. Wong, D. Mikhailidis, 2020, Nutrition Research Reviews.

Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer

B. Salehi, J. Sharifi‐Rad, S. Raza, 2020, Cancer Cell International.

The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease.

Ž. Reiner, Z. Asemi, E. Aghadavod, 2019, Food & function.

Mutation detection in Croatian patients with Familial Hypercholesterolemia

S. Humphries, I. Pećin, Ž. Reiner, 2013, Annals of human genetics.

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors

I. Pećin, Ž. Reiner, G. Hovingh, 2017, European journal of preventive cardiology.

'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias.

M. Taskinen, G. De Backer, P. Filardi, 2011, European heart journal.

Management of patients with familial hypercholesterolaemia

Ž. Reiner, 2015, Nature Reviews Cardiology.

A comparison of European and US guidelines for familial hypercholesterolaemia

Ž. Reiner, 2015, Current opinion in lipidology.

In silico interactions of statins with cell death-inducing DNA fragmentation factor-like effector A (CIDEA).

V. Echeverria, Ž. Reiner, G. Ashraf, 2021, Chemico-biological interactions.

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.

W. März, M. Banach, J. Zamorano, 2021, Atherosclerosis.

Statin therapy and sex hormones.

Ž. Reiner, C. A. Stamerra, P. Giorgini, 2020, European journal of pharmacology.

Are anti-inflammatory agents and nutraceuticals - novel inhibitors of PCSK9?

Ž. Reiner, Z. Asemi, Rana Shafabakhsh, 2020, Critical reviews in food science and nutrition.

Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study

K. Kotseva, D. Wood, G. Backer, 2020, European journal of preventive cardiology.

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

J. De Sutter, R. Peters, S. Wiedmann, 2019, Atherosclerosis.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Diederick Grobbee, Davor Milicic, Dirk De Bacquer, 2019, European journal of preventive cardiology.

Macrophage: A key therapeutic target in atherosclerosis?

Ž. Reiner, A. Sahebkar, Jamshid Gholizadeh Navashenaq, 2019, Current pharmaceutical design.

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials

A. Sahebkar, M. Banach, S. Atkin, 2018, BMJ Open.

Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials

A. Sahebkar, M. Banach, C. Sirtori, 2018, Annals of medicine.

Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.

Yunes Panahi, Amirhossein Sahebkar, A. Sahebkar, 2017, Complementary therapies in medicine.

Resistance and intolerance to statins.

Ž. Reiner, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.

Kees Hovingh, Handrean Soran, Emilio Ros, 2014, Atherosclerosis.

Primary Prevention of Cardiovascular Disease with Statins in the Elderly

Ž. Reiner, 2014, Current Atherosclerosis Reports.

Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey.

Ž. Reiner, E. Tedeschi-Reiner, Z. Sonicki, 2010, Preventive medicine.

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

Dirk De Bacquer, G. De Backer, D. De Bacquer, 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.

Nikolaus Marx, Takashi Kadowaki, Alberto Zambon, 2008, The American journal of cardiology.

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

F. Sacks, P. Zimmet, C. Wanner, 2008, Diabetes & vascular disease research.

Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease.

Ž. Reiner, Zeljko Reiner, M. Strozzi, 2005, The American journal of cardiology.

Effects of Rice Policosanol on Serum Lipoproteins, Homocysteine, Fibrinogen and C-Reactive Protein in Hypercholesterolaemic Patients

Ž. Reiner, Ž. Romić, E. Tedeschi-Reiner, 2005, Clinical drug investigation.

The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration

C. de Beaufort, H. Schunkert, H. Bueno, 2022, GMS health innovation and technologies.

Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia.

Ž. Reiner, F. Montecucco, F. Carbone, 2020, Reviews of physiology, biochemistry and pharmacology.

Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.

Dirk De Bacquer, G. De Backer, D. De Bacquer, 2015, Atherosclerosis.

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

A. Khera, D. Panagiotakos, J. Jozwiak, 2022, Journal of cachexia, sarcopenia and muscle.

Molecular and Biological Functions of Quercetin as a Natural Solution for Cardiovascular Disease Prevention and Treatment

Ž. Reiner, Z. Asemi, Rana Shafabakhsh, 2020, Plant Foods for Human Nutrition.

Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis

A. Sahebkar, M. Banach, Ž. Reiner, 2019, Archives of medical science : AMS.

Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".

J. Borén, M. Banach, D. Noto, 2018, Atherosclerosis.

The Role of Nutraceuticals in Statin Intolerant Patients.

D. Panagiotakos, B. Paulweber, A. Sahebkar, 2018, Journal of the American College of Cardiology.

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

D. Panagiotakos, B. Paulweber, A. Sahebkar, 2017, Nutrition reviews.

Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries

J. De Sutter, W. Sheu, D. Grobbee, 2016, European journal of preventive cardiology.

[The effects of plant sterols on hypercholesterolemia].

Ž. Reiner, E. Tedeschi-Reiner, 2007, Lijecnicki vjesnik.

Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study)

Ž. Reiner, D. Miličić, M. Bergovec, 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.

Ž. Reiner, E. Tedeschi-Reiner, Z. Sonicki, 2004, Croatian medical journal.

The role of statins in lung cancer

M. Banach, Farzaneh Fathi, Ž. Reiner, 2021, Archives of medical science : AMS.

Changes in Butyrylcholinesterase Activity and Serum Lipids after Oxprenolol and Glibenclamide Treatments in Non-diabetic Rats

Ž. Reiner, P. Konjevoda, V. Bradamante, 2006, Arzneimittelforschung.

Butyrylcholinesterase activity and plasma lipids in dexamethasone treated rats.

Ž. Reiner, M. Peraica, B. Radić, 2005, Acta Pharmaceutica.

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

Jeroen J. Bax, R. de Caterina, B. Gorenek, 2009 .

Clinical Study on the Effect of Simvastatin on Butyrylcholinesterase Activity

Ž. Reiner, Ž. Metelko, V. Bradamante, 2005, Arzneimittelforschung.

patients The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic

F. Sacks, P. Zimmet, C. Wanner, 2011 .

Renal transplantation in patients with Balkan endemic nephropathy.

P. Kes, N. Bašić-Jukić, Ž. Reiner, 2007, Transplantation proceedings.

Statins for the primary prevention of cardiovascular disease (Review)

Mark D. Huffman, S. Ebrahim, Ž. Reiner, 2011 .

Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study

A. Sahebkar, M. Banach, Ž. Reiner, 2022, Frontiers in Cardiovascular Medicine.

Regular exercise behaviour and intention and symptoms of anxiety and depression in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey

J. Wellmann, G. De Backer, D. De Bacquer, 2017, European Journal of Preventive Cardiology.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

L. A. Bonet, P. Kirchhof, D. Atar, 2010, European journal of heart failure.

Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.

Ž. Reiner, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

The 2013 ESH/ESC guidelines for the management of arterial hypertension

Helmut Baumgartner, Jens Jordan, Michael Böhm, 2013 .

Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis.

A. Sahebkar, I. Pećin, Ž. Reiner, 2016, International journal of cardiology.

Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19

M. Banach, Ž. Reiner, K. Al-Rasadi, 2020, Angiology.

The perception and knowledge of cardiovascular risk factors among medical students

Ž. Reiner, E. Tedeschi-Reiner, Z. Sonicki, 2012, Croatian medical journal.

Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases

Ž. Reiner, Seyed Saeed Tamehri Zadeh, A. Sahebkar, 2022, Inflammopharmacology.

Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network.

E. Hagström, Pankaj Gupta, Wolfgang Reinhardt, 2023, Atherosclerosis.

Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

A. Sahebkar, Ž. Reiner, S. Aslani, 2022, Mediators of Inflammation.

Impact of Intravenous Trehalose Administration in Patients with Niemann–Pick Disease Types A and B

O. Rajabi, Ž. Reiner, M. Mobini, 2022, Journal of clinical medicine.

HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study

S. Atkin, Ž. Reiner, T. Sathyapalan, 2023, Cells.

Effect of green cardamom on lipoproteins, glycemic control and anthropometric parameters: A meta-analysis of randomized clinical trials.

Ž. Reiner, F. Kolahdooz, Z. Asemi, 2020, Clinical Nutrition ESPEN.

Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey

P. Heuschmann, U. Keil, R. Cífková, 2015, European journal of preventive cardiology.

Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry.

J. De Sutter, J. Deckers, D. De Bacquer, 2019, Journal of hypertension.

Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials.

Ž. Reiner, A. Sahebkar, A. Cicero, 2016, Metabolism: clinical and experimental.

Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality

Ž. Reiner, I. Graham, M. Cooney, 2012, Current Cardiology Reports.

JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda

D. Atar, A. Hoes, S. Priori, 2016 .

Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1

A. Sahebkar, C. Catena, G. Colussi, 2016, Thrombosis and Haemostasis.

Is lipoprotein(A) a risk factor for atherosclerosis of the retinal arteries?

Ž. Reiner, E. Tedeschi-Reiner, R. Ivekovic, 2002, Collegium Antropologicum.

The burden of hyperlipidaemia and diabetes in cardiovascular diseases

Ž. Reiner, M. Merkler, 2007, Fundamental & clinical pharmacology.

The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials.

Ž. Reiner, F. Kolahdooz, H. Mirzaei, 2020, Complementary therapies in medicine.

Cardiovascular disease (CVD) risk factors in older adults - Perception and reality.

Ž. Reiner, Z. Sonicki, Josipa Mazalin Protulipac, 2015, Archives of gerontology and geriatrics (Print).

Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology.

S. Achenbach, J. Schuijf, S. Schroeder, 2011, European heart journal.

The effect of nuts consumption on circulating oxidized low‐density lipoproteins: A systematic review and meta‐analysis of randomized controlled trials

A. Sahebkar, Ž. Reiner, A. Eid, 2023, Phytotherapy research : PTR.

Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey

J. Wellmann, G. De Backer, D. De Bacquer, 2011, Journal of hypertension.

The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease

Ž. Reiner, M. Taghizadeh, Z. Asemi, 2020, Lipids in Health and Disease.

Dietary management of patients at high risk for cardiovascular disease; EUROASPIRE V.

D. De Bacquer, K. Kotseva, P. Jankowski, 2023, Clinical nutrition ESPEN.

The year in cardiology 2018: prevention

U. Laufs, U. Landmesser, Ž. Reiner, 2019, European heart journal.

Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey

J. Wellmann, G. De Backer, D. De Bacquer, 2015, European journal of preventive cardiology.

Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project.

G. De Backer, D. De Bacquer, K. Kotseva, 2012, European Heart Journal.

Statins and the COVID-19 main protease: in silico evidence on direct interaction

M. Banach, Ž. Reiner, F. Montecucco, 2020, Archives of medical science : AMS.

Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.

A. Hoes, D. Grobbee, E. Mirrakhimov, 2020, European journal of preventive cardiology.

Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?

R. Cífková, B. Jug, Ž. Reiner, 2022, Atherosclerosis.

Guidelines, position papers and critical reviews: differences and similarities

Ž. Reiner, 2013, European journal of preventive cardiology.

Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus: A Global Case–Control Study in 13 Countries

F. Sacks, E. Bonora, C. Wanner, 2013, Circulation.

Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes : A Global Case-Control Study in 13 Countries Running title :

F. Sacks, E. Bonora, C. Wanner, 2013 .

Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology

P. Kes, N. Božina, Ž. Reiner, 2007, Clinical Chemistry and Laboratory Medicine.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

J. De Sutter, P. Heuschmann, J. Tuomilehto, 2015, Cardiovascular Diabetology.

[Less salt--more health. Croatian action on salt and health (CRASH)].

B. Jelaković, Ž. Reiner, D. Miličić, 2016, Liječnički vjesnik.

Comorbidities and Syndemics in the COVID-19 Age: Challenges and Opportunities for Bringing Separated Branches of Medicine Closer to Each Other.

Ž. Reiner, D. Miličić, N. Sartorius, 2021, Psychiatria Danubina.

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the international lipid expert panel (ILEP).

M. Banach, G. Latkovskis, Ž. Reiner, 2023, Progress in cardiovascular diseases.

Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.

G. De Backer, D. De Bacquer, K. Kotseva, 2016, Atherosclerosis.

Can we further optimize statin therapy to increase tolerability?

C. Sirtori, Ž. Reiner, M. Ruscica, 2019, Expert opinion on drug discovery.

Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects

Ž. Reiner, A. Sahebkar, A. Mohammadpour, 2021, Journal of cardiovascular development and disease.

Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey.

G. De Backer, D. De Bacquer, K. Kotseva, 2013, Atherosclerosis.

Effect of orlistat on plasma lipids and body weight: A systematic review and meta‐analysis of 33 randomized controlled trials

A. Sahebkar, P. Kovanen, Ž. Reiner, 2017, Pharmacological research.

Compendium of Abridged ESC Guidelines 2011

Helmut Baumgartner, Angelo Auricchio, Jeroen J. Bax, 2012 .

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome

A. Sahebkar, S. Atkin, Ž. Reiner, 2023, Frontiers in Endocrinology.

Differential Expression of miRNA-223 in Coronary In-Stent Restenosis

A. Sahebkar, Ž. Reiner, S. H. Aghaee-Bakhtiari, 2022, Journal of clinical medicine.

Mitochondrial myopathy associated with a novel 5522G>A mutation in the mitochondrial tRNATrp gene

Ž. Reiner, W. Sperl, Zoran Mitrović, 2012, European Journal of Human Genetics.

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

J. Zamorano, P. Filardi, R. Ferrari, 2016, European heart journal supplements : journal of the European Society of Cardiology.

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients

M. Nematy, Ž. Reiner, L. Goshayeshi, 2021, Frontiers in Cardiovascular Medicine.

Ž. Reiner, 2015, Kardiologia polska.

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.

T. Lüscher, C. Ballantyne, K. Khaw, 2014, European heart journal.

A systematic review and meta-analysis: The effects of probiotic supplementation on metabolic profile in patients with neurological disorders.

A. Milajerdi, Ž. Reiner, H. Mirzaei, 2020, Complementary Therapies in Medicine.

Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: A four-year follow-up

M. Petrovecki, Ž. Reiner, Ž. Metelko, 2010, Wiener klinische Wochenschrift.

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from twenty four European countries

Dragan, Lale, P. Heuschmann, 2016 .

The effects of omega-3 fatty acids supplementation on metabolic status in pregnant women: a systematic review and meta-analysis of randomized controlled trials

M. Mansournia, A. Milajerdi, Ž. Reiner, 2020, Journal of Diabetes and Metabolic Disorders.

Safety of red yeast rice supplementation: A systematic review and meta‐analysis of randomized controlled trials

A. Sahebkar, M. Banach, G. Watts, 2019, Pharmacological research.

The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.

Ž. Reiner, N. Ghanbari, Z. Asemi, 2020, Clinical Nutrition ESPEN.

Educational level and risk profile and risk control in patients with coronary heart disease

D. De Bacquer, K. Kotseva, R. Cífková, 2016, European journal of preventive cardiology.

Is there a better future of healthy aging?

Ž. Reiner, M. Kujundžić Tiljak, M. Klarica, 2020, Croatian Medical Journal.

At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products

Ž. Reiner, A. Sahebkar, M. Varmaghani, 2020, Journal of Medical Economics.

An update on regional variation in cardiovascular mortality within Europe

W. Lieb, H. Schunkert, D. Bacquer, 2008 .

Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys

G. De Backer, D. De Bacquer, K. Kotseva, 2016, European Journal of Preventive Cardiology.

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats

M. Maleki, Ž. Reiner, A. Sahebkar, 2023, Journal of clinical medicine.

Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches.

A. Sahebkar, Ž. Reiner, Seyed Mohammad Gheibi Hayat, 2022, Endocrine, Metabolic & Immune Disorders - Drug Targets.

Prevalence and types of persistent dyslipidemia in patients treated with statins

Ž. Reiner, E. Tedeschi-Reiner, 2013, Croatian medical journal.

Mental disorders, treatment response, mortality and serum cholesterol: a new holistic look at old data.

Ž. Reiner, D. Miličić, M. Jakovljevič, 2007, Psychiatria Danubina.

Management of overweight and obese patients with coronary heart disease across Europe

K. Kotseva, U. Keil, J. Dallongeville, 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

The effects of spirulina on glycemic control and serum lipoproteins in patients with metabolic syndrome and related disorders: A systematic review and meta‐analysis of randomized controlled trials

A. Milajerdi, Ž. Reiner, F. Kolahdooz, 2019, Phytotherapy Research.

Changes in Serum Lipid and Lipoprotein Levels in Postmenopausal Patients with Node-Positive Breast Cancer Treated with Tamoxifen

Ž. Reiner, B. Belev, D. Vrbanec, 1998, Tumori.

Flaxseed Supplementation Reduces Plasma Lipoprotein(a) Levels: A Meta-Analysis.

A. Sahebkar, N. Ward, Ž. Reiner, 2019, Alternative therapies in health and medicine.

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Steffen E. Petersen, O. Franco, I. V. Van Gelder, 2016, European journal of preventive cardiology.

Diabetic dyslipidemia or ‘diabetes lipidus’?

Ž. Reiner, D. Muačević-Kataneć, 2011, Expert review of cardiovascular therapy.

A. Hoes, D. Grobbee, E. Mirrakhimov, 2021, European Journal of Preventive Cardiology.

Clinical Study on the Effect of Simvastatin on Paraoxonase Activity

Ž. Reiner, Z. Babić, V. Bradamante, 2007, Arzneimittelforschung.

Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health within the general population: Recommendations from the EACPR (Part I) Short title: Exercise and PA characteristics in primary prevention

D., T. Takken, A. Cohen-Solal, 2012 .

Guidelines for the diagnosis and treatment of pulmonary hypertension

G. Filippatos, P. Vardas, M. Humbert, 2009 .

The effects of cortisol, 11-epicortisol, and lysine vasopressin on DNA and RNA synthesis in isolated human adrenocorticotropic hormone-secreting pituitary tumor cells

D. Lüdecke, Ž. Reiner, J. Rešetić, 1990, Steroids.

Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology ( ESC )

Mike Kirby, Jeroen J. Bax, Bulent Gorenek, 2011 .

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

I. V. Van Gelder, B. Lewis, L. Fauchier, 2021, European heart journal.

ESC/EAS Guidelines for the Management of Dyslipidaemias

M. Taskinen, P. Filardi, S. Agewall, 2013 .

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

D. Panagiotakos, B. Paulweber, A. Sahebkar, 2017, Archives of medical science : AMS.

Statins in the primary prevention of cardiovascular disease

Ž. Reiner, 2013, Nature Reviews Cardiology.

How much do Croatian Physicians and Croatian Population Know about Risk Factor for Cadiovascular Diseases

Ž. Reiner, E. Tedeschi-Reiner, Z. Sonicki, 2011 .

Acute pancreatitis after ocrelizumab treatment for relapsing remitting multiple sclerosis.

I. Pećin, Ž. Reiner, M. Habek, 2020, Multiple sclerosis and related disorders.

Effect of statins on the blood lipid profile in patients with different cardiovascular diseases: a systematic review with meta-analysis of randomized clinical trials .

A. Sahebkar, Ž. Reiner, S. Aslani, 2022, Current medicinal chemistry.

Third universal definition of myocardial infarction

Jeroen J. Bax, P. Kirchhof, D. Atar, 2013, Nature Reviews Cardiology.

[Low HDL-cholesterol--an important risk factor for cardiovascular diseases].

Ž. Reiner, D. Muačević-Kataneć, E. Tedeschi-Reiner, 2011, Lijecnicki vjesnik.

Third universal definition of myocardial infarction.

Jeroen J. Bax, P. Kirchhof, D. Atar, 2012, Journal of the American College of Cardiology.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

L. A. Bonet, P. Kirchhof, G. Lip, 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

ESC/EAS Guidelines for the Management of Dyslipidaemias

M. Taskinen, P. Filardi, S. Agewall, 2013 .

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit

D. Atar, G. Filippatos, A. Hoes, 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

The Role of Nutraceuticals in Statin Intolerant Patients.

D. Panagiotakos, B. Paulweber, A. Sahebkar, 2018, Journal of the American College of Cardiology.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2013, European heart journal.

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

Jeroen J. Bax, R. de Caterina, B. Gorenek, 2014 .

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

D. Atar, G. Filippatos, A. Hoes, 2007 .

ESC Guidelines on the management of cardiovascular diseases during pregnancy

Jeroen J. Bax, N. Al-Attar, B. Gorenek, 2011 .

New ESC/EAS Guidelines for the management of dyslipidaemias − any controversies behind the consensus?

Ž. Reiner, 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey.

Ž. Reiner, E. Tedeschi-Reiner, Z. Sonicki, 2010, Atherosclerosis.

Combined therapy in the treatment of dyslipidemia

Ž. Reiner, 2010, Fundamental & clinical pharmacology.

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2007, Blood pressure.

Spontaneous perforation of the small intestine, a novel manifestation of classical homocystinuria in an adult with new cystathionine beta-synthetase gene mutations.

R. Zadro, Ž. Reiner, I. Barić, 2011, Collegium antropologicum.

The effect of trehalose administration on the serum expression levels of microRNAs associated with lipid metabolism and autophagy process in patients with myocardial infarction - the post-hoc analysis of the TREAT-IR trial.

A. Sahebkar, M. Banach, Ž. Reiner, 2023, Archives of Medical Science.

Salt intake and metabolic syndrome. Croatian action on salt and health (CRASH)

B. Jelaković, I. Pećin, Ž. Reiner, 2011 .

Salt mapping in Croatian. Croatian action on salt and health (CRASH)